Peer-to-Peer Reviews vs. Written Appeals: When to Use Each

The denial letter arrived. Now what?

Most practices treat peer-to-peer reviews and written appeals as interchangeable — pick whichever one sounds faster and fire it off. That's a mistake. The two mechanisms work differently, succeed under different conditions, and require different preparation. Choosing the wrong one wastes time and often results in a second denial.

The right choice almost always comes down to one question: why was the request denied?

What a Peer-to-Peer Review Actually Is

A peer-to-peer (P2P) review is a direct phone conversation between your physician and the payer's medical director. You're not submitting paperwork — you're making a clinical argument in real time.

Payers are required to offer this option, and most have defined timeframes within which you must request it: typically 14-30 days from the denial date, though this varies by payer and state. Miss the window and you lose the option entirely.

The conversation runs 15-30 minutes on average. The payer's medical director has the file in front of them. Your job is to add clinical context that the written request didn't convey — not to repeat what was already submitted.

What a Written Appeal Is

A written appeal is a formal submission that asks the payer to reconsider the denial based on new or additional evidence. It goes through a different review channel than the original request — typically a utilization management team or a specialized appeals department.

KFF research on Medicare Advantage appeals shows that a significant share of denied claims are overturned on appeal — sometimes more than half — which tells you something important: most denials aren't clinically unwinnable. They're administratively deficient.

Written appeals have longer timelines. Standard appeals typically resolve within 30-60 days. Expedited appeals (for urgent cases) run 72 hours under CMS rules. Plan accordingly.

When to Request a Peer-to-Peer

P2P is most effective when the denial was based on a misunderstanding of the patient's clinical situation — not a documentation gap, but a context gap.

Use a P2P when:

The denial reason is "not medically necessary" without specific documentation cited. This often means the payer's reviewer didn't have enough clinical context to justify approval. A physician conversation can fill that gap in minutes that a document never could.

The patient has an unusual presentation. Standard payer criteria are written for typical cases. If your patient has comorbidities, contraindications to first-line therapies, or a disease course that doesn't follow the expected pattern, a live conversation lets you explain why the textbook criteria don't apply here.

The denial came from an automated review system. Algorithm-generated denials are notoriously context-free. A medical director conversation breaks the automation loop.

You need a fast resolution. P2P decisions often come back same-day or within 24 hours. If the patient is waiting on treatment, this is typically faster than the written appeal track.

How to Prepare for a P2P Call

You have one shot. The medical director is not your adversary, but they are skeptical and time-constrained. Preparation makes the difference:

Pull the specific denial reason and the payer's clinical coverage policy before the call. Know which criteria they claim aren't met.
Have the patient's chart open. Be ready to cite specific lab values, scores (DAS28, PASI, CDAI), and prior treatment history with dates and outcomes.
Prepare two or three clinical statements that directly address the denial reason. Don't summarize the case — make the argument.
Know the drug's approved indications and the payer's specific LCD/NCD language. Use their terminology, not your own.
Keep it under 10 minutes if possible. Medical directors are doing multiple P2Ps per day. Concise and specific wins.

When to Write a Written Appeal

Written appeals are the right tool when the denial is based on missing documentation — and you have that documentation, or can get it.

Use a written appeal when:

The denial letter cites specific missing items. "No documentation of DMARD failure" or "lab values not provided" — these are fixable with a written submission. You know exactly what to include.

You have new clinical evidence. If lab results came in after the original submission, or the patient had a documented adverse reaction to a step-therapy drug that wasn't in the original file, a written appeal lets you submit that evidence formally.

You want to include published literature. Clinical guidelines from ACR, AAD, or peer-reviewed studies supporting your treatment choice carry more weight in writing than in a 20-minute phone call.

The denial was a coverage determination, not a medical necessity question. If the payer is claiming the drug isn't covered under the patient's plan, that's a benefit dispute — not a clinical argument. Written appeals with plan documents and coverage language are the right vehicle.

The P2P failed. If you already did a P2P and the medical director upheld the denial, a written appeal escalates to a different reviewer and gives you a second bite. Include a note that the P2P was unsuccessful and attach any new supporting material.

Common Written Appeal Mistakes

The most common mistake: repeating the original submission word-for-word. If the same documentation didn't work the first time, it won't work the second time. A written appeal needs to add something — new evidence, a direct response to each denial reason, or clinical literature the original request didn't include.

Other mistakes that kill appeals:

Missing deadlines. Most payers give 60-180 days from denial to file an appeal. Missing it forfeits your right entirely. Calendar the deadline the moment the denial letter arrives.
Generic language. "The requested medication is medically necessary for this patient" is not an argument. Cite the specific coverage criteria and explain point-by-point why they're met.
Emotional framing. The appeal is a clinical and administrative document. Statements about patient suffering — while real — don't move payer reviewers. Clinical evidence does.
Not addressing every denial reason. If the denial cites three criteria not met, address all three. Leaving one unaddressed gives the reviewer an easy reason to uphold.

The Decision Framework in Practice

When a denial lands, run through this sequence:

Read the denial reason carefully. Is it a documentation gap or a clinical context gap?
If it's a context gap — and you can make the clinical case verbally — request a P2P immediately.
If it's a documentation gap — and you have the missing documentation — write the appeal with that documentation attached.
If the patient is urgent, pursue both tracks simultaneously where the payer allows it.
If neither option is moving, escalate to your state insurance commissioner or file a grievance through the plan. Both create paper trails that matter.

The goal isn't to master appeals — it's to need them less. Documentation quality on the first submission is the only reliable way to reduce your denial rate. When prior auth requests include complete clinical data, payer-specific criteria addressed directly, and proper prior treatment documentation, the denial rate drops significantly before you ever reach the P2P or appeal stage.

One More Thing About Timing

Both options have deadlines that most practices track poorly. A 30-day P2P request window disappears fast when staff are managing a queue of 40 open cases. A 90-day appeal window sounds long until a month passes unnoticed.

Build a tracking system — even a simple spreadsheet — that logs denial date, P2P request deadline, appeal deadline, and current status for every open denial. The practices that win appeals most consistently aren't the ones with the best clinical arguments. They're the ones who show up on time with the documentation actually prepared.

Sources:
Kaiser Family Foundation. (2024). Medicare Advantage Appeal Outcomes and Audit Findings. kff.org
American College of Rheumatology. (2025). Clinical Practice Guidelines. acr.org
American Academy of Dermatology. (2025). Clinical Guidelines and Evidence-Based Practice. aad.org
Centers for Medicare & Medicaid Services. (2024). Medicare Appeals Process — Expedited and Standard Timelines. cms.gov
American Medical Association. (2025). Prior Authorization Peer-to-Peer Review Best Practices. ama-assn.org